{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:12:52Z","timestamp":1791490372562,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> In a shock state, naloxone generates the cardiovascular pressor effect by displacing the endogenous opiate\u2010like peptide \u03b2\u2010endorphin, resulting in restoration of the normal response to catecholamines. In addition to this opioid antagonistic effect, the non\u2010opiate receptor\u2010mediated effect has also been proposed. The aim of this study was to define the mechanism of non\u2010opiate receptor\u2010mediated action of naloxone.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> In guinea\u2010pig ventricular tissues, cumulative concentration\u2013response curves for isoproterenol as well as for forskolin and 3\u2010isobutylmethylxanthine (IBMX) were obtained by increasing the concentration stepwise. To assess the effect on the phosphodiesterase (PDE), the effects of naloxone on contractile forces induced by isoproterenol (0.05\u2003\u03bcM) in the presence of IBMX, cilostamide (a PDE III inhibitor), or rolipram (a PDE IV inhibitor) were observed. Naloxone\u2010induced changes in cAMP production by isoproterenol both in the absence and in the presence of IBMX were measured. Naloxone\u2010induced changes in cAMP production by forskolin in the presence of IBMX were also measured.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Naloxone (30\u2003\u03bcM) produced a leftward shift of the isoproterenol concentration\u2013response curve (0.01\u20132\u2003\u03bcM) without changing the maximal response. Forskolin (0.5\u201310\u2003\u03bcM) produced a concentration\u2010dependent increase in contractile forces. Naloxone increased the maximal inotropic response of forskolin. Naloxone showed no effect on the IBMX concentration\u2013response curve. In the presence of IBMX (200\u2003\u03bcM), naloxone did not alter the contractions evoked by isoproterenol or forskolin. Whereas naloxone increased contractile forces significantly (approximately 25%) more than that of isoproterenol in the presence of rolipram, no alteration of contractile forces in the cilostamide\u2010incubated muscles was observed. Naloxone caused a concentration\u2010related increase of cAMP in the absence of IBMX, but caused no change in its presence.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> The enhancement of myocardial contractility by naloxone in the presence of stimulation of adenylyl cyclase activity appears to be mediated by inhibition of PDE, specifically PDE III.<\/jats:p>","DOI":"10.1111\/j.1399-6576.2009.02023.x","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T14:11:02Z","timestamp":1246371062000},"page":"1043-1051","source":"Crossref","is-referenced-by-count":10,"title":["Phosphodiesterase inhibition by naloxone augments the inotropic actions of \u03b2\u2010adrenergic stimulation"],"prefix":"10.1111","volume":"53","author":[{"given":"W. K.","family":"PARK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H.","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"CHAE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. L.","family":"CHO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"AHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.197601"},{"key":"e_1_2_6_3_2","first-page":"347","article-title":"Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock","volume":"16","author":"Lechner RB","year":"1985","journal-title":"Circ Shock"},{"key":"e_1_2_6_4_2","first-page":"157","article-title":"Naloxone potentiates the inotropic effects of isoproterenol in vitro by a nonopiate receptor mechanism","volume":"38","author":"Lechner RB.","year":"1992","journal-title":"Circ Shock"},{"key":"e_1_2_6_5_2","first-page":"317","article-title":"Naloxone potentiates contractile responses to epinephrine in isolated canine arteries","volume":"31","author":"Caffrey JL","year":"1990","journal-title":"Circ Shock"},{"key":"e_1_2_6_6_2","first-page":"206","article-title":"(+)Naloxone potentiates the inotropic effect of epinephrine in the isolated dog heart","volume":"40","author":"Gu H","year":"1993","journal-title":"Circ Shock"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000265155.01815.6d"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501118"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_6_10_2","first-page":"H272","article-title":"Intracoronary naloxone in hemorrhagic shock","volume":"249","author":"Lechner RB","year":"1985","journal-title":"dose-dependent stereospecific effects"},{"key":"e_1_2_6_11_2","first-page":"102","article-title":"Direct myocardial depressant effect of naloxone","volume":"48","author":"Kim KJ","year":"2004","journal-title":"mechanical and electrophysiological actions in vitro"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.54.2.231"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199011000-00016"},{"key":"e_1_2_6_14_2","first-page":"513","article-title":"Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility","volume":"11","author":"Weishaar RE","year":"1987","journal-title":"J Cyclic Nucleotide Protein Phosphor Res"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb11158.x"},{"key":"e_1_2_6_16_2","first-page":"91P","article-title":"Effects of rolipram on guinea\u2010pig ventricles in vitro","volume":"87","author":"Gristwood RW","year":"1986","journal-title":"evidence of an unexpected synergism with SK&F 94120"},{"key":"e_1_2_6_17_2","first-page":"698","article-title":"Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium","volume":"342","author":"Shahid M","year":"1990","journal-title":"positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199003000-00015"},{"key":"e_1_2_6_19_2","first-page":"715","article-title":"Effects of a cardiotonic quinolinone derivative Y\u201020487 on the isoproterenol\u2010induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium","volume":"20","author":"Katano Y","year":"1992","journal-title":"comparison with rolipram, Ro 20-1724, milrinone and isobutylmethylxanthine"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90384-6"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00167264"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197605000-00008"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00058-9"},{"key":"e_1_2_6_24_2","first-page":"751","article-title":"High\u2010dose naloxone","volume":"15","author":"Groeger JS","year":"1987","journal-title":"pharmacokinetics in patients in septic shock"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2009.02023.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2009.02023.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:37:24Z","timestamp":1696955844000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2009.02023.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1399-6576.2009.02023.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2009.02023.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}